Literature DB >> 3067504

Systemic amyloid deposition in old age and dementia of Alzheimer type: the relationship of brain amyloid to other amyloid.

M Yamada1, H Tsukagoshi, E Otomo, M Hayakawa.   

Abstract

We investigated amyloid deposition in the brain and other organs in 105 consecutive autopsy cases, aged 59 to 101 years. They consisted of two groups; 15 patients with dementia of Alzheimer type (DAT) and 90 patients without DAT. Amyloid deposition was found in 93% of all cases. The incidence of amyloid deposition increased with age. The number of organs affected with amyloid deposition in each case also increased with age. The incidence of amyloid deposition in each organ was as follows; 88% in pituitary gland, 66% in brain [amyloid of senile plaque (SP) (61%) and/or cerebral amyloid angiopathy (CAA) (56%)], 33% in pancreas, 3% in heart, and less in others. In immunohistochemical studies using the antisera to the various kinds of amyloid or related proteins, amyloid beta protein was demonstrated in brain amyloids including SP and CAA, but not in others. Cardiac amyloid was positive for prealbumin. Pituitary amyloid and CAA were positive for amyloid P-component. The incidence of brain amyloids in DAT were significantly higher than that in non-DAT. There was no significant difference in the incidence of pituitary and pancreatic amyloid between DAT and non-DAT. In the non-DAT patients, there were significant positive correlations in amyloid deposition between the brain and pituitary gland and between the brain and pancreas. Acceleration of amyloid deposition would be a process confined to the brain in the patients with DAT. The pathogenesis of the accelerated deposition of brain amyloids is discussed from the point of view of amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3067504     DOI: 10.1007/bf00687423

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  20 in total

1.  Two new lesions in Alzheimer's disease.

Authors:  P Averback
Journal:  Lancet       Date:  1983-11-19       Impact factor: 79.321

2.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

3.  Senile amyloid deposition.

Authors:  T Ishii; Y Hosoda; N Ikegami; H Shimada
Journal:  J Pathol       Date:  1983-01       Impact factor: 7.996

Review 4.  Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-12       Impact factor: 91.245

5.  Senile cardiac amyloidosis: evidence of two different amyloid substances in the ageing heart.

Authors:  P Westermark; B Johansson; J B Natvig
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

6.  Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.

Authors:  J R Wright; E Calkins; R L Humphrey
Journal:  Lab Invest       Date:  1977-03       Impact factor: 5.662

Review 7.  Senile amyloidosis: a protean manifestation of the aging process.

Authors:  G G Cornwell; P Westermark
Journal:  J Clin Pathol       Date:  1980-12       Impact factor: 3.411

8.  Senile amyloidosis: principles of localization in a heterogeneous form of amyloidosis.

Authors:  S Störkel; J Bohl; H M Schneider
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1983

9.  Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related.

Authors:  C W Wong; V Quaranta; G G Glenner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

Authors:  R E Tanzi; J F Gusella; P C Watkins; G A Bruns; P St George-Hyslop; M L Van Keuren; D Patterson; S Pagan; D M Kurnit; R L Neve
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

View more
  10 in total

1.  Complement neoantigen and vitronectin are components of plaques in amyloid AL neuropathy.

Authors:  G L Zanusso; G Moretto; B Bonetti; S Monaco; N Rizzuto
Journal:  Ital J Neurol Sci       Date:  1992-09

2.  Multifactorial genesis of neuroradiological "leucoencephalopathies.".

Authors:  K Kuchelmeister; G Fahrendorf; F Gullotta; M Tegenthoff
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

3.  Senile amyloidoses of the pituitary and adrenal glands. Morphological and statistical investigations.

Authors:  C Röcken; B Eick; W Saeger
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

4.  Soluble brain homogenates from diverse human and mouse sources preferentially seed diffuse Aβ plaque pathology when injected into newborn mouse hosts.

Authors:  Brenda D Moore; Yona Levites; Guilian Xu; Hailey Hampton; Munir F Adamo; Cara L Croft; Hunter S Futch; Corey Moran; Susan Fromholt; Christopher Janus; Stefan Prokop; Dennis Dickson; Jada Lewis; Benoit I Giasson; Todd E Golde; David R Borchelt
Journal:  Free Neuropathol       Date:  2022-03-23

5.  Amyloid-P-component-like immunoreactivity in beta/A4-immunoreactive deposits in Alzheimer-type dementia brains.

Authors:  M Kimura; H Arai; T Takahashi; N Iwamoto
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

6.  Investigation of the Presence of Apotipoprotein E, G lycosaminoglycans, Basement Membrane Proteins, and Protease inhibitors in Senile interstitial Amyloid of the Pituitary.

Authors:  Christoph Rocken; Diana Paris; Karen Steusloff; Wolfgang Saeger
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

7.  Subarachnoid haemorrhage in the elderly: a necropsy study of the association with cerebral amyloid angiopathy.

Authors:  M Yamada; Y Itoh; E Otomo; M Hayakawa; T Miyatake
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

8.  Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.

Authors:  Shanker Swaminathan; Li Shen; Shannon L Risacher; Karmen K Yoder; John D West; Sungeun Kim; Kwangsik Nho; Tatiana Foroud; Mark Inlow; Steven G Potkin; Matthew J Huentelman; David W Craig; William J Jagust; Robert A Koeppe; Chester A Mathis; Clifford R Jack; Michael W Weiner; Andrew J Saykin
Journal:  Brain Imaging Behav       Date:  2012-03       Impact factor: 3.978

9.  Brain Perfusion Change in Patients with Mild Cognitive Impairment After 12 Months of Aerobic Exercise Training.

Authors:  Binu P Thomas; Takashi Tarumi; Min Sheng; Benjamin Tseng; Kyle B Womack; C Munro Cullum; Bart Rypma; Rong Zhang; Hanzhang Lu
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.160

10.  Cerebral amyloid angiopathy: early presentation in a patient with prior neurosurgical interventions. Case report.

Authors:  Alec Clark; Arnav Barpujari; Brandon Lucke-Wold; Ken Porche; Dimitri Laurent; Matthew Koch; Matthew Decker
Journal:  Rom Neurosurg       Date:  2021-12-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.